Join leading experts from the FDA, industry, and academia at CHI’s 18th Annual Immunogenicity & Bioassay Summit, taking place October 19–22, 2026, in Alexandria, VA and virtually.
This premier meeting offers unmatched opportunities to connect with regulatory leaders and scientific peers while exploring the latest advances in immunogenicity risk assessment, bioassay development, and clinical strategies.
With strong FDA representation, interactive discussions, and a vibrant exhibit and poster hall, the summit provides the insights and networking you need to move your programs forward.
We look forward to welcoming you this October in Alexandria, VA!